Sector
Healthcare
Industry
Medical - Diagnostics & Research
Employees
1462
First IPO Date
September 10, 2015
| Name | Title | Pay | Year Born |
| Marcus Wolfinger | Chairman of Board of Management & Chief Executive Officer | 764,000 | 1967 |
| Georg Bauer | Director for Sales & Member of Management Board | 451,000 | 1973 |
| Claus Vielsack | Director of Product Development & Member of Board of Management | 567,000 | 1967 |
| Jan Keppeler | Head of Investor Relations, Sustainability & Corporate Communications | 0 | N/A |
| Hermann Leistner | Founder & Advisor | 0 | 1946 |
| Tanja Bucherl | Chief Financial Officer & Member of Management Board | 0 | 1988 |
Stratec SE, a company established in 1979 and headquartered in Birkenfeld, Germany (which operated as STRATEC Biomedical AG until December 2018), specializes in the development and production of advanced automation and instrumentation solutions. These offerings primarily serve the in-vitro diagnostics and life sciences industries across Germany, the European Union, and international markets. The company's operations are divided into three principal segments. The Instrumentation division focuses on designing and manufacturing sophisticated automated analyzer systems, complete with service components and consumables, for clients in clinical diagnostics and biotechnology. Diatron delivers integrated systems, various components, consumables, and testing kits specifically for low-throughput applications in hematology and clinical chemistry. Lastly, the Smart Consumables segment is dedicated to innovating and producing intelligent consumable products for use in diagnostics, life sciences, and medical technologies.